Prognostic impact and therapeutic implications of sentinel lymph node micro-metastases in early-stage breast cancer patients
✍ Scribed by Carsten T. Viehl; Igor Langer; Ulrich Guller; Rosanna Zanetti-Dällenbach; Holger Moch; Edward Wight; Daniel Oertli; Markus Zuber
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 67 KB
- Volume
- 103
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The prognostic value of sentinel lymph node (SLN) micro‐metastases and the question whether patients with SLN micro‐metastases should undergo axillary lymph node dissection remain a matter of great debate. Based on the current literature and on our own data, we provide suggestive evidence that SLN micro‐metastases in early stage breast cancer patients appear to have prognostic value and should impact the decision‐making regarding adjuvant therapy, however, do not necessarily require further surgical treatment. J. Surg. Oncol. 2011;103:531–533. © 2011 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## BACKGROUND. Thirty percent of lymph node negative patients with operable breast carcinoma experience disease recurrence within 10 years. Retrospective serial sectioning of axillary lymph nodes has revealed undetected metastases in 9 -30% of these patients. These occult metastases have been show
The risk of an internal mammary lymph node (IMN) metastasis and its prognostic value for patients with invasive breast cancer were assessed by evaluating 142 patients who had either a mastectomy with lymph node dissection or a biopsy of the IMN. By univariate analysis, overall survival significantly
## Abstract ## BACKGROUND. The feasibility and accuracy of sentinel lymph node (SLN) biopsy in patients with breast cancer after preoperative chemotherapy has been demonstrated in a number of large, single‐institution studies. However, a relative contraindication to SLN biopsy after preoperative c